• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study

    Credits

    1 Contact Hour(s)

    Release Date

    Monday, November 16, 2015

    Offline Date

    Thursday, November 16, 2017

    ACPE Expiration Date

    Friday, November 16, 2018

    Target Audience

    Pharmacist, Nurse

    Cost

    $0.00

    • Overview

      Deprescribing is defined as "the systematic process of identifying and discontinuing drugs in instances in which existing or potential harms outweighs existing or potential benefits in the context of an individual patient's care goals, current level of functioning, life expectancy, values, and preferences." The process of both effective prescribing and deprescribing requires shared decision-making between all involved parties, informed patient consent, and close monitoring. Pharmacists can play a pivotal roll prior to prescribing, straight through recommending deprescribing. However, before even beginning the conversation of deprescribing, it is necessary to understand why it is so important to discontinue medications in the aforementioned instances.

      Rating

         4.50  out of 5

      Handouts

      • Homestudy PDF :   homestudypdf_0798999915153H01.pdf

      Financial Support By

      Maryland Pharmacists Association
    • Pharmacist

      List at least 3 examples of medications which may be eligible for discontinuation in advanced illness and cite the evidence that supports deprescribing.
      Define polypharmacy and describe risks associated with use of five or more medications concurrently.
      Given a patient, describe a strategic process to assess the risks and benefits of medications and evaluate their eligibility for discontinuation.

      Nurse

      Given a patient, describe a strategic process to assess the risks and benefits of medications and evaluate their eligibility for discontinuation.
      List at least 3 examples of medications which may be eligible for discontinuation in advanced illness and cite the evidence that supports deprescribing.
      Define polypharmacy and describe risks associated with use of five or more medications concurrently.
    • Activity Type

      Knowledge

      CE Broker

      20-530062

      Universal Activity Number

      Pharmacist 0798-9999-15-153-H01-P
      Nurse 0798-9999-15-153-H01-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher
    Adobe Acrobat Reader


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).